Shandong Pharmaceutical Glass Co., Ltd. (600529.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 18.31

From 52W high−16.58%

Volume3.05M

Market capCNY 12.42B

P/E (TTM)18.0x

P/S (TTM)2.7x

Div yield2.50%

Key dataSep 18, 2026

Open

CNY 18.31

From 52W high

−16.58%

Volume

3.05M

Market cap

CNY 12.42B

ValuationView details →

P/E (Fwd)

33.5x

EV/EBITDA

7.9x

P/E (TTM)

18.0x

RSI (14)

40.2

MomentumView details →

1D Return

−0.11%

YTD Return

−7.53%

ValuationView details →

P/E (Fwd)

33.5x

P/E (TTM)

18.0x

EV/EBITDA

7.9x

EV/Sales

2.1x

P/S (TTM)

2.7x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

33.44%

Net Margin

14.75%

EBITDA Margin

27.15%

ROE (TTM)

7.97%

ROA (TTM)

6.58%

Asset Turnover

0.45x

GrowthView details →

Revenue YoY

−6.74%

EPS YoY

−29.81%

FCF YoY

+7.46%

Revenue CAGR 3Y

+2.23%

EPS CAGR 3Y

+0.32%

EBITDA YoY

—

MomentumView details →

1D Return

−0.11%

YTD Return

−7.53%

1Y Return

−15.11%

RSI (14)

40.2

vs 50D SMA

−3.09%

vs 200D SMA

−4.49%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.79x

Quick Ratio

2.75x

Div Yield

2.50%

Div Rate

CNY 0.46

Div Growth 1Y

−14.29%

EarningsView details →

EPS (Actual)

CNY 0.26

EPS Surprise

−30.83%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.29

Avg Surprise (4Q)

−30.83%

Rev Surprise

−6.57%

Financials snapshotView financials →

Revenue (TTM)

4.52B

Net Income (TTM)

667.20M

Op. CF (TTM)

699.38M

Next earningsOct 22, 2026 →

Latest newsMore news →

Shanghai Stock Exchange issued a review inquiry letter to Shandong Pharmaceutical Glass regarding its application for a targeted private placement of shares.2d ago

Shandong Pharmaceutical Glass's application to issue A-shares to specific investors was accepted by the Shanghai Stock Exchange for review.3d ago

Similar companies

Crown Holdings, Inc.CCK Jia Yao Holdings Limited01626.HK Ball CorporationBALL 紫江企业600210.SH International Paper CompanyIP Amcor plcAMCR Find similar companies →

Latest newsMore news →

Shanghai Stock Exchange issued a review inquiry letter to Shandong Pharmaceutical Glass regarding its application for a targeted private placement of shares.2d ago Shandong Pharmaceutical Glass's application to issue A-shares to specific investors was accepted by the Shanghai Stock Exchange for review.3d ago Shandong Pharmaceutical Glass disclosed its semi-annual report on August 24, reporting revenue of 2.28 billion yuan (up 1.34% year-on-year) and net profit attributable to shareholders of 371 million yuan (down 0.07% year-on-year).27d ago